Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
US5633244A · kind A · utility
24Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 16, 1995 |
| Grant date | May 27, 1997 |
| Priority date | — |
| Expiry date | May 16, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61F2210/0047
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A synergistic pharmaceutical combination or composition is disclosed for the treatment of gastritis and peptic ulcer containing a therapeutic amount of a histamine H.sub.2 receptor blocking agent, which increases intragastric pH, and an acid degradable antibacterial compound. In particular, the combination is directed to the treatment of infections by Helicobacter pylori by raising the bioavailability of acid degradable antibacterial compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.